GlassScriptPhysician profile
Jennifer S Roy
NPI 1780211607
$1,298.17
in general payments reported to CMS, 2019-2025
19 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.53 · 2024: $128 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $282.92 | 2024-2025 | Fasenra, Tezspire, Airsupra |
| Merck Sharp & Dohme LLC | $235.64 | 2024-2025 | Winrevair, Keytruda, Welireg |
| Regeneron Healthcare Solutions, INC. | $133.64 | 2025 | Dupixent |
| Genzyme Corporation | $92.58 | 2025 | |
| Viatris Specialty LLC | $87.22 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $79.53 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $61.69 | 2025 | Uptravi |
| Glaxosmithkline, LLC. | $59.55 | 2025 | Trelegy Ellipta |
| Insmed, INC. | $36.46 | 2025 | Arikayce |
| Novartis Pharmaceuticals Corporation | $33.01 | 2025 | |
| Ani Pharmaceuticals, INC. | $29.80 | 2025 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $26.86 | 2025 | Trodelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.20 | 2025 | |
| Baxter Healthcare | $23.63 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Sobi, INC | $21.12 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $20.35 | 2024 | Somatuline Depot, Onivyde |
| Exact Sciences Corporation | $17.53 | 2023 | Cologuard Collection Kit |
| Inogen, INC. | $15.91 | 2025 | |
| Lilly USA, LLC | $14.53 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.